RAB42 and glioblastoma: These results are partially consistent with previous studies showing that RAB42 could serve as a prognostic marker for glioblastoma (GBM) (Sun et al., 2022), liver cancer (Peng et al., 2022) and some other types of cancers (Zheng et al., 2022).